Scientists in York have discovered that lung cancer could be diagnosed with a simple blood test.
Early detection of lung cancer has been proven to save lives.
Dr Dawn Coverley, who is based at the University’s Department of Biology and is funded by Yorkshire Cancer Research, has found that an altered form of a protein called Ciz1 is present in lung cancers, even when they are at a very early stage.
Kathryn Scott, Head of Research Funding for Yorkshire Cancer Research, said:
Cizzle Biotech, a spin out company from the University of York that is funded primarily by Yorkshire Cancer Research, the White Rose Seed Fund and Finance Yorkshire, is now translating the research into a test suitable for use in hospital diagnostic laboratories.